Fit for the road after cardiac surgery? A single-center-study using the “Test for the registration of traffic-specific personality traits” (TVP) in 120 patients after cardiac surgery

2013 ◽  
Vol 61 (S 01) ◽  
Author(s):  
B Gansera ◽  
K Schmid ◽  
A Hapfelmeier ◽  
L Gansera ◽  
W Eichinger
2007 ◽  
Vol 10 (6) ◽  
pp. E449-E458 ◽  
Author(s):  
David Bracco ◽  
Nicolas Noiseux ◽  
Marc-Jacques Dubois ◽  
Ignacio Prieto ◽  
Fadi Basile ◽  
...  

2020 ◽  
Vol 34 (2) ◽  
pp. 401-408
Author(s):  
Khalil Raissouni ◽  
Andranik Petrosyan ◽  
Ghislain Malapert ◽  
Saed Jazayeri ◽  
Marie-Catherine Morgant ◽  
...  

2012 ◽  
Vol 94 (4) ◽  
pp. 1302-1306 ◽  
Author(s):  
Raffaele Giordano ◽  
Gaetano Palma ◽  
Vincenzo Poli ◽  
Sergio Palumbo ◽  
Veronica Russolillo ◽  
...  

2020 ◽  
Author(s):  
Wim Vandenberghe ◽  
Lien Van Laethem ◽  
Alexander Zarbock ◽  
Melanie Meersch ◽  
Eric A.J. Hoste

AbstractIntroductionAcute kidney injury occurs in up to one third of patients after cardiac surgery and is an important contributor for adverse outcome. Previous research has demonstrated the benefit of a bundle of preventive measurements to reduce AKI in a subgroup of patients with high risk for AKI development. Urinary stress biomarkers [TIMP-2]*[IGFBP7] are used to identify these patients who are at risk for AKI. The trial aims to investigate the potential discrepancy between biomarker results and clinical estimation of occurrence of AKI on ICU in clinical practice.Methods and analysisWe plan to include 100 adult patients after cardiac surgery with cardiopulmonary bypass in a prospective, single center clinical trial. After cardiac surgery, different type of healthcare professional in ICU will provide a prediction of AKI occurrence and severity in the next 48 hours by filling in a questionnaire just before and after [TIMP-2]*[IGFBP7] biomarker analysis. Primary, this trial investigates the potential discrepancy in AKI prediction between clinical estimation by healthcare providers, biomarker results, and previous described score systems. Secondly, the impact of knowledge of the biomarker result on the quality of prediction by healthcare providers will be evaluated.Ethics and disseminationThis prospective, single center study has been approved by the medical ethical committee of the Ghent University Hospital (28th May 2019, trial registration number B670201939991). Informed consent was obtained for patients and healthcare providers.Summary strength and limitations-Influence of knowledge of a kidney biomarker on healthcare providers’ assessment of risk for AKI in clinical setting-Different types of healthcare providers with various expertise-It is a single center study with limited number of patients


2017 ◽  
Vol 153 (2) ◽  
pp. 450-458.e1 ◽  
Author(s):  
Punkaj Gupta ◽  
Andrew Wilcox ◽  
Tommy R. Noel ◽  
Jeffrey M. Gossett ◽  
Stephanie R. Rockett ◽  
...  

Heart & Lung ◽  
2020 ◽  
Author(s):  
Raffaele Giordano ◽  
Giuseppe Comentale ◽  
Luigi Di Tommaso ◽  
Ettorino Di Tommaso ◽  
Vito Antonio Mannacio ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document